68466-11-5

Upstream product

• 3674-13-3 2,3-dibromopropionic acid ethyl ester 
• 95-55-6 2-amino-phenol 
• 98-88-4 benzoyl chloride 
• 22244-22-0 ethyl 3,4-dihydro-2H-benzo [b][1,4]oxazine-2-carboxylate 

Downstream Products

• 68281-42-5 ethyl 4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate 
• 890839-38-0 4-Benzyl-3,4-dihydro-2H-benzo[1,4]oxazine-2-carbonitrile 
• 212578-42-2 4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide 
• 96988-59-9 4-benzyl-2-(2-imidazolinyl)-3,4-dihydro-2H-1,4-benzoxazine hydrochloride 
• 1401074-90-5 (2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)-2H-benzo[b][1,4]oxazin-4(3H)-yl)(phenyl)methanone 
• 1401076-76-3 (2-(hydroxymethyl)-2H-benzo[b][1,4]oxazin-4(3H)-yl)(phenyl)methanone 
• 1401076-78-5 (4-benzoyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)methyl-4-methylbenzenesulfonate 

Relevant academic research and scientific papers

BENZO [B] [1, 4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors of Formula (I).